| Patent | Date |
|---|
Compositions and methods for double-targeting virus infections and targeting cancer cells
Grant 8,138,200 - Kucera , et al. March 20, 2 | 2012-03-20 |
Lipid analogs for combating tumors
Grant 8,106,032 - Kucera , et al. January 31, 2 | 2012-01-31 |
Phospholipids for the Treatment of Infection by Togaviruses, Herpes Viruses and Coronaviruses
App 20100273740 - FLEMING; Ronald A. ; et al. | 2010-10-28 |
Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells
App 20100184718 - KUCERA; Louis S. ; et al. | 2010-07-22 |
Compositions and methods for targeting cancer cells
Grant 7,638,528 - Kucera , et al. December 29, 2 | 2009-12-29 |
Lipid analogs for combating tumors
App 20080293667 - Kucera; Louis S. ; et al. | 2008-11-27 |
Compositions and methods for targeting cancer cells
Grant 7,309,696 - Kucera , et al. December 18, 2 | 2007-12-18 |
Lipid analogs for inhibiting HIV-1 activity
Grant 7,294,620 - Kucera , et al. November 13, 2 | 2007-11-13 |
Lipid analogs for inhibiting the activity of hepatitis B antigen
Grant 7,294,619 - Kucera , et al. November 13, 2 | 2007-11-13 |
Lipid analogs for combating tumors
Grant 7,294,621 - Kucera , et al. November 13, 2 | 2007-11-13 |
Lipid analogs for inhibiting HIV-1 activity
App 20070105812 - Kucera; Louis S. ; et al. | 2007-05-10 |
Lipid analogs for inhibiting the activity of hepatitis B antigen
App 20070105811 - Kucera; Louis S. ; et al. | 2007-05-10 |
Lipid analogs for combating tumors
App 20070099870 - Kucera; Louis S. ; et al. | 2007-05-03 |
Lipid analogs for treating viral infections
Grant 7,141,557 - Kucera , et al. November 28, 2 | 2006-11-28 |
Compositions and methods for targeting cancer cells
App 20060264397 - Kucera; Louis S. ; et al. | 2006-11-23 |
Lipid analogs for treating viral infections
Grant 7,135,584 - Kucera , et al. November 14, 2 | 2006-11-14 |
Lipid analogs for treating viral infections
Grant 7,129,227 - Kucera , et al. October 31, 2 | 2006-10-31 |
Compositions and methods of double-targeting virus infections and cancer cells
Grant 7,026,469 - Kucera , et al. April 11, 2 | 2006-04-11 |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
App 20050187192 - Fleming, Ronald A. ; et al. | 2005-08-25 |
Methods and compositions for the treatment of respiratory syncytial virus
App 20050187191 - Kucera, Louis S. ; et al. | 2005-08-25 |
Lipid analogs for treating viral infections
App 20050080050 - Kucera, Louis S. ; et al. | 2005-04-14 |
Lipid analogs for treating viral infections
App 20040259845 - Kucera, Louis S. ; et al. | 2004-12-23 |
Compositions and methods for targeting cancer cells
App 20040161398 - Kucera, Louis S. ; et al. | 2004-08-19 |
Compositions and methods for double-targeting virus infections and targeting cancer cells
Grant 6,670,341 - Kucera , et al. December 30, 2 | 2003-12-30 |
9-[(5-dihydroxyboryl)-pentyl] purines, useful as an inhibitor of inflammatory cytokines
App 20030022864 - Ishaq, Khalid S. ; et al. | 2003-01-30 |
Compositions and methods of double-targeting virus infections and cancer cells
App 20020082242 - Kucera, Louis S. ; et al. | 2002-06-27 |
Lipid analogs for treating viral infections
Grant 5,962,437 - Kucera , et al. October 5, 1 | 1999-10-05 |
N-substituted-(Dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines
Grant 5,643,893 - Benson , et al. July 1, 1 | 1997-07-01 |
Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
Grant 5,614,548 - Piantadosi , et al. March 25, 1 | 1997-03-25 |
Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
Grant 5,550,132 - Benson , et al. August 27, 1 | 1996-08-27 |
| 